Abstract
P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the blood-brain barrier and in several peripheral organs. In order to understand the role of P-gp in physiological and patho-physiological conditions, several carbon-11 labelled P-gp tracers have been developed and validated. This review provides an overview of the spectrum of radiopharmaceuticals that is available for this purpose. A short overview of the physiology of the blood-brain barrier in health and disease is also provided. Tracer kinetic modelling for quantitative analysis of P-gp function and expression is highlighted, and the advantages and disadvantages of the various tracers are discussed.
Keywords: PET, P-glycoprotein, blood-brain barrier, radiopharmaceuticals, tracer-kinetic modeling, Carbon-11 Labeled Tracers, P-Glycoprotein Function, P-gp tracers, Alzheimer's disease, Epilepsy, Parkinson's disease, Multidrug resistance-associated proteins (MRP), Substrates, Inhibitors, Nucleotide-binding domains (NBDs), ATP hydrolysis, Modulators, Constant of dissociation (Kd), β-amyloid peptide (Aβ), Radiolabeling, cytochrome P450 (cyp 450), [11C]verapamil, [11C]colchicine, [11C]daunorubicin, [11C]loperamide, [11C]/[18F]paclitaxel, [11C]Docetaxel, [11C]D617, [11C]Carvedilol, [11C]Laniquidar, [11C]Elacridar, [11C]MC18, [11C]Tariquidar
Current Topics in Medicinal Chemistry
Title: Carbon-11 Labeled Tracers for In Vivo Imaging of P-Glycoprotein Function: Kinetics, Advantages and Disadvantages
Volume: 10 Issue: 17
Author(s): Gert Luurtsema, Joost Verbeek, Mark Lubberink, Adriaan A. Lammertsma, Rudi Dierckx, Philip Elsinga, Albert D. Windhorst and Aren van Waarde
Affiliation:
Keywords: PET, P-glycoprotein, blood-brain barrier, radiopharmaceuticals, tracer-kinetic modeling, Carbon-11 Labeled Tracers, P-Glycoprotein Function, P-gp tracers, Alzheimer's disease, Epilepsy, Parkinson's disease, Multidrug resistance-associated proteins (MRP), Substrates, Inhibitors, Nucleotide-binding domains (NBDs), ATP hydrolysis, Modulators, Constant of dissociation (Kd), β-amyloid peptide (Aβ), Radiolabeling, cytochrome P450 (cyp 450), [11C]verapamil, [11C]colchicine, [11C]daunorubicin, [11C]loperamide, [11C]/[18F]paclitaxel, [11C]Docetaxel, [11C]D617, [11C]Carvedilol, [11C]Laniquidar, [11C]Elacridar, [11C]MC18, [11C]Tariquidar
Abstract: P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the blood-brain barrier and in several peripheral organs. In order to understand the role of P-gp in physiological and patho-physiological conditions, several carbon-11 labelled P-gp tracers have been developed and validated. This review provides an overview of the spectrum of radiopharmaceuticals that is available for this purpose. A short overview of the physiology of the blood-brain barrier in health and disease is also provided. Tracer kinetic modelling for quantitative analysis of P-gp function and expression is highlighted, and the advantages and disadvantages of the various tracers are discussed.
Export Options
About this article
Cite this article as:
Luurtsema Gert, Verbeek Joost, Lubberink Mark, A. Lammertsma Adriaan, Dierckx Rudi, Elsinga Philip, D. Windhorst Albert and van Waarde Aren, Carbon-11 Labeled Tracers for In Vivo Imaging of P-Glycoprotein Function: Kinetics, Advantages and Disadvantages, Current Topics in Medicinal Chemistry 2010; 10 (17) . https://dx.doi.org/10.2174/156802610792928013
DOI https://dx.doi.org/10.2174/156802610792928013 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment
Current Topics in Medicinal Chemistry Mechanism-Based Treatment in Chronic Neuropathic Pain: The Role of Antidepressants
Current Pharmaceutical Design Angiotensin II, Cell Proliferation and Angiogenesis Regulator: Biologic and Therapeutic Implications in Cancer
Current Vascular Pharmacology The Role of IGF-1 Receptor and Insulin Receptor Signaling for the Pathogenesis of Alzheimers Disease: From Model Organisms to Human Disease
Current Alzheimer Research Self-Assembling Peptides: Potential Role in Tumor Targeting
Current Pharmaceutical Biotechnology From Anti-allergic to Anti-Alzheimer ’ s: Molecular Pharmacology of Dimebon™
Current Alzheimer Research Current Review of Small Molecule Ret Kinase Inhibitors
Mini-Reviews in Medicinal Chemistry DNA Double Strand Breaks: A Common Theme in Neurodegenerative Diseases
Current Alzheimer Research Current Molecularly Targeting Therapies in NSCLC and Melanoma
Anti-Cancer Agents in Medicinal Chemistry A Proteomic Analysis of Mitochondrial Complex III Inhibition in SH-SY5Y Human Neuroblastoma Cell Line
Current Proteomics The Role of 3D Pharmacophore Mapping Based Virtual Screening for Identification of Novel Anticancer Agents: An Overview
Current Topics in Medicinal Chemistry Neurotransmitters and Substances of Abuse: Effects on Adult Neurogenesis
Current Neurovascular Research Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery
Current Pharmaceutical Design Interactions Between Cholinergic and Fibroblast Growth Factor Receptors in Brain Trophism and Plasticity
Current Protein & Peptide Science Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Zebrafish as a Model System to Screen Radiation Modifiers
Current Genomics Glycosaminoglycans, Protein Aggregation and Neurodegeneration
Current Protein & Peptide Science Therapeutic Peptide Mimetics Looking for a Turn to Block Aberrant Players of Malignancy
Current Cancer Therapy Reviews Valproic Acid As Anti-Cancer Drug
Current Pharmaceutical Design Relevance of Multidrug Resistance Proteins on the Clinical Efficacy of Cancer Therapy
Current Drug Delivery